ERCC1 and cervical carcinoma: Similar to our research, Choi et al. (Choi et al., 2020) built a group of five DEG markers, namely, BCL2, HER2, CD133, CAIX and ERCC1, which can be used to predict the response to chemotherapy and prognosis of cervical cancer.